• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Swiss markets watchdog approves first crypto assets fund

September 29, 2021 by David Barret Leave a Comment

September 29, 2021

ZURICH (Reuters) – Switzerland’s financial markets supervisor said on Wednesday it had approved the country’s first fund that invests primarily in crypto assets.

The Crypto Market Index Fund is restricted to qualified investors and categorised under “other funds for alternative investments” with particular risks, the Swiss Financial Market Supervisory Authority (FINMA) said in a statement.

Crypto assets are based on the blockchain or distributed ledger technology.

“In order to facilitate serious innovation, FINMA applies the existing provisions of financial market laws in a consistently technology-neutral way,” it added, thus ensuring that new technologies are not used to circumvent existing rules.

Since crypto assets involve particular risks, FINMA said it had tied the approval to specific requirements, including that the fund may invest only in established assets with a sufficiently large trading volume.

Investments also must be made through established counterparties and platforms that are based in a member country of the Financial Action Task Force and are subject to corresponding anti-money laundering regulations, FINMA said.

(Reporting by Michael Shields; Editing by Ramakrishnan M.)

Source Link Swiss markets watchdog approves first crypto assets fund

David Barret
David Barret

Related posts:

  1. UK has foiled 31 terror plots in the last four years – spy chief
  2. Strong winds, high temperatures fuel wildfire near Spanish resort
  3. Golf-U.S. play Ryder Cup for country, Europe for something more
  4. Chile’s 2022 draft budget seeks to tame deficit after pandemic splurge, Pinera says

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • US Just Killed NASA’s Mars Sample Return Mission – So What Happens Now?
  • Art Sleuths May Have Recovered Traces Of Da Vinci’s DNA From One Of His Drawings
  • Countries With The Most Narcissists Identified By 45,000-Person Study, And The Results Might Surprise You
  • World’s Oldest Poison Arrows Were Used By Hunters 60,000 Years Ago
  • The Real Reason You Shouldn’t Eat (Most) Raw Cookie Dough
  • Antarctic Scientists Have Just Moved The South Pole – Literally
  • “What We Have Is A Very Good Candidate”: Has The Ancestor Of Homo Sapiens Finally Been Found In Africa?
  • Europe’s Missing Ceratopsian Dinosaurs Have Been Found And They’re Quite Diverse
  • Why Don’t Snorers Wake Themselves Up?
  • Endangered “Northern Native Cat” Captured On Camera For The First Time In 80 Years At Australian Sanctuary
  • Watch 25 Years Of A Supernova Expanding Into Space Squeezed Into This 40-Second NASA Video
  • “Diet Stacking” Trend Could Be Seriously Bad For Your Health
  • Meet The Psychedelic Earth Tiger, A Funky Addition To “10 Species To Watch” In 2026
  • The Weird Mystery Of The “Einstein Desert” In The Hunt For Rogue Planets
  • NASA Astronaut Charles Duke Left A Touching Photograph And Message On The Moon In 1972
  • How Multilingual Are You? This New Language Calculator Lets You Find Out In A Minute
  • Europa’s Seabed Might Be Too Quiet For Life: “The Energy Just Doesn’t Seem To Be There”
  • Amoebae: The Microscopic Health Threat Lurking In Our Water Supplies. Are We Taking Them Seriously?
  • The Last Dogs In Antarctica Were Kicked Out In April 1994 By An International Treaty
  • Interstellar Comet 3I/ATLAS Snapped By NASA’s Europa Mission: “We’re Still Scratching Our Heads About Some Of The Things We’re Seeing”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version